Physical and mental health impacts during COVID-19 quarantine in adolescents with preexisting chronic immunocompromised conditions

Carregando...
Imagem de Miniatura
Citações na Scopus
9
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
SOC BRASIL PEDIATRIA
Citação
JORNAL DE PEDIATRIA, v.98, n.4, p.350-361, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective: To evaluate physical and mental health indicators in adolescents with preexisting chronic immunocompromised conditions during coronavirus disease 2019 (COVID-19) quarantine. Methods: A cross-sectional study included 355 adolescents with chronic conditions and 111 healthy adolescents. An online self-rated survey was used to investigate socio-demographic features, healthcare routine, and the quarantine impact on physical and mental health. The validated self-reported version of the Strengths and Difficulties Questionnaire (SDQ) was also applied. Results: The median of age [14 (10-18) vs. 15 (10-18) years, p = 0.733] and frequencies of female (61% vs. 60%, p = 0.970) were similar between adolescents with preexisting chronic conditions and healthy adolescents during quarantine of COVID-19 pandemic. The frequencies of abnormal total difficulties score of SDQ were similar in patients and controls (30% vs. 31%, p = 0.775). Logistic regression analysis showed that being female (OR = 1.965; 95% CI = 1.091-3.541, p = 0.024), fear of underlying disease activity/complication (OR = 1.009; 95%CI = 1.001-1.018, p = 0.030) were associated with severe psychosocial dysfunction in adolescents with chronic conditions, whereas school homework (OR = 0.449; 95% CI = 0.206-0.981, p = 0.045) and physical activity (OR = 0.990; 95% CI = 0.981-0.999, p = 0.030) were protective factors. Further analysis of patients with chronic immunocompromised conditions and previous diagnosis of mental disorders (9%) compared with patients without diagnosis showed higher median of total difficulties score (p = 0.001), emotional (p = 0.005), conduct (p = 0.007), peer problems (p = 0.001) and hyperactivity (p = 0.034) in the former group. Conclusion: Adolescents with preexisting chronic immunocompromised conditions during COVID-19 quarantine were not at higher risk of adverse health indicators. Being female, fear of underlying disease activity/complication, and household members working outside of the home were relevant issues for adolescents with preexisting chronic conditions. This study reinforces the need to establish mental health strategies for teens with chronic conditions, particularly during the pandemic. (C) 2021 Published by Elsevier Editora Ltda. on behalf of Sociedade Brasileira de Pediatria.
Palavras-chave
COVID-19 pandemic, Mental health, Adolescents, Chronic diseases
Referências
  1. APA A.P.A., 2013, DIAGNOSTIC STAT MANU, V5th ed.
  2. Bates LC, 2020, CHILDREN-BASEL, V7, DOI 10.3390/children7090138
  3. BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706
  4. EHCAP, SCOR STRENGTH DIFF Q
  5. Elnaggar RK, 2020, ASIA-PAC J PUBLIC HE, V32, P491, DOI 10.1177/1010539520963564
  6. Fegert JM, 2020, CHILD ADOL PSYCH MEN, V14, DOI 10.1186/s13034-020-00329-3
  7. FleitlichB CortazarPG, 2000, INFANTOREVNEUROPSIQU, V8, P44
  8. Gotzinger F, 2020, LANCET CHILD ADOLESC, V4, P653, DOI 10.1016/S2352-4642(20)30177-2
  9. Gruber R, 2020, SLEEP MED, V76, P33, DOI 10.1016/j.sleep.2020.09.015
  10. Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928
  11. HusbyS KoletzkoS, 2020, JPEDIATRGASTROENTERO, V70
  12. Kovess-Masfety V, 2016, SOC PSYCH PSYCH EPID, V51, P1093, DOI 10.1007/s00127-016-1253-0
  13. LevinA StevensPE, 2013, KIDNEYINTSUPPL, V3, P1
  14. Levine A, 2014, J PEDIATR GASTR NUTR, V58, P795, DOI 10.1097/MPG.0000000000000239
  15. Lucendo AJ, 2017, UNITED EUR GASTROENT, V5, P335, DOI 10.1177/2050640616689525
  16. Martinelli M, 2020, INFLAMM BOWEL DIS, V26, pE95, DOI 10.1093/ibd/izaa136
  17. Mieli-Vergani G, 2018, J PEDIATR GASTR NUTR, V66, P345, DOI 10.1097/MPG.0000000000001801
  18. Munasinghe S, 2020, J ADOLESCENT HEALTH, V67, P653, DOI 10.1016/j.jadohealth.2020.08.008
  19. Pedrosa T, 2020, LUPUS, V29, P1978, DOI 10.1177/0961203320957098
  20. PettyRE SouthwoodTR, 2004, JRHEUMATOL, V31, P390
  21. Polanczyk GV, 2015, J CHILD PSYCHOL PSYC, V56, P345, DOI 10.1111/jcpp.12381
  22. PouwelsKB HouseT, 2021, LANCETPUBLICHEALTH, V6, P30
  23. Riecher-Rossler A, 2017, LANCET PSYCHIAT, V4, P8, DOI 10.1016/S2215-0366(16)30348-0
  24. SafadiMA SilvaCA, 2020, REVPAULPEDIATR, V39
  25. Serlachius A, 2020, JMIR PEDIATR PARENT, V3, DOI 10.2196/23057
  26. Sethi S, 2016, J AM SOC NEPHROL, V27, P1278, DOI 10.1681/ASN.2015060612
  27. Silva CA, 2020, CLINICS, V75, DOI 10.6061/clinics/2020/e1931
  28. Singh S, 2020, PSYCHIAT RES, V293, DOI 10.1016/j.psychres.2020.113429
  29. Sousa BLA, 2020, CLINICS, V75, DOI 10.6061/clinics/2020/e2273
  30. Vugteveen J, 2020, ASSESSMENT, V27, P1476, DOI 10.1177/1073191118804082